AVITA Medical (RCEL) Debt to Equity (2023 - 2025)
AVITA Medical posted quarterly Debt to Equity of -$2.58 for Q4 2025, down 127.49% year-on-year from $9.39 in Q4 2024, and up 59.46% on a QoQ basis from -$6.37 in Q3 2025.
AVITA Medical (RCEL) has 3 years of Debt to Equity data on file, last reported at -$2.58 in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity fell 127.49% year-over-year to -$2.58; the trailing twelve-month figure through Dec 2025 stood at -$2.58 (down 127.49% YoY), and the FY2025 full-year result was -$2.58, down 127.49% from the prior year.
- Debt to Equity for Q4 2025 stood at -$2.58, up from -$6.37 in the prior quarter.
- Across five years, Debt to Equity topped out at $9.39 in Q4 2024 and bottomed at -$9.73 in Q1 2025.
- The 3-year median for Debt to Equity is $0.81 (2023), against an average of -$0.61.
- The widest annual swing landed in 2024, when Debt to Equity soared 1057.01%; it then slumped 867.08% in 2025.
- A 3-year view of Debt to Equity shows it stood at $0.81 in 2023, then soared by 1057.01% to $9.39 in 2024, then tumbled by 127.49% to -$2.58 in 2025.
- The last three Debt to Equity figures came in at -$2.58 (Q4 2025), -$6.37 (Q3 2025), and -$3.51 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn | -2.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.58 |
| Sep 30, 2025 | -6.37 |
| Jun 30, 2025 | -3.51 |
| Mar 31, 2025 | -9.73 |
| Dec 31, 2024 | 9.39 |
| Sep 30, 2024 | 3.48 |
| Jun 30, 2024 | 1.71 |
| Mar 31, 2024 | 1.27 |
| Dec 31, 2023 | 0.81 |